Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Nitroglycerin for Chronic Anal Fissure
NCT05590520Unknown
- Sponsor
- Pak Emirates Military Hospital
- Start
- Nov 2022
- Primary completion
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of Onabotulinumtoxina + hydrogel in anal fissure (2 arms), sponsored by Pak Emirates Military Hospital. Primary endpoint: Healing of fissure at 6 weeks. Status: unknown.
02
Drugs
Onabotulinumtoxina + hydrogel
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT05590520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590520.